Table 1 Changes in cDNA of TCO candidate genes on 19p13.2

From: Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas

PCR product

Change in cDNA

Type of aa change

dbSNP

Het frequency in TCO patients (%)

Het frequency in controls (%)

TIMM44x4

G344A

Silent

12.5

NA

TIMM44 x9

C925A

P308Q

12.5

0

TIMM44 x13

G1274A

Silent

12.5

0

TIMM44x13

C1307T

Silent

rs1157923

12.5

NA

ELAVL1x3

G509A

Silent

12.5

NA

ELAVL1x5

T971C

Silent

12.5

NA

ELAVL1x5

A4024G

3′UTR

rs12983784

37.5

NA

CCL25x3

A303G

H101R

rs2032887

62.5

NA

CCL25x3

C312T

T104M

rs2113089

12.5

NA

CCL25x4

G379A

Silent

rs2303164

37.5

29.7

CCL25x5

G675A

3′UTR

rs2287936

25.0

NA

CCL25x5

G868T

3′UTR

12.5

NA

ADAMTS10x4

C646G

T134S

rs7255721

37.5

NA

ADAMTS10x26

T3548G

H1101Q

rs7252299

90.0

NA

ANGPTL4x7

G1362A

Silent

rs11672433

12.5

NA

LASS1x3

C591A

Silent

8.0

NA

LASS4x9

C997T

Silent

rs1127912

12.5

NA

LASS4x9

T1006C

Silent

rs36247

37.5

NA

LASS4x12

T1339C

V353A

rs17160348

12.0

NA

LASS4x12

G1376A

A366T

rs36259

88.0

NA

RAB11Bx5

C558T

Silent

rs2230876

57.0

NA

MARCH2x1

C20T

5′UTR

rs12150986

42.0

NA

MARCH2x2

A615G

T54A

rs11882865

67.0

NA

MARCH2x5

G1111C

R219P

rs34099346

42.9

22.5

MARCH2x5

del(CTTCCACTTCAAC) bp1267-1280

3′UTR

13.0

3.0

GRIM19x1

C182T

5′UTR

25.0

NA

EDG5x2

A919C

Silent

rs2116942

14.2

NA

EDG5x2

A866T

T289M

14.2

NA

  1. aa=amino acid; cDNA=complementary; NA=not available; PCR=polymerase chain reaction; TCO=thyroid tumor with cell oxyphilia.